cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline Heavy-chain antibody targeting of CD38
Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience CD38 connects the heart and brain Translational Psychiatry The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18




